Ember and Bob, there were some points that the orgs and / or individuals did not fully agree. So, the wording on some of the parts of the letter had to be broadened to get a consensus. And, as Bob said, that was the point of the letter, to find and speak unitedly on what we agree on. The more who give that same message on what we agree on, the more likely we can make a change on that point. But continually focusing on what we disagree on, what there isn't enough evidence to prove, will just continue to give government officials an excuse to do nothing.This is the whole point of coalitions and membership associations. Find where you agree and work to create change on those points. Don't become stagnant in continual disagreements. Keep focused on the big picture, the end goal.
By the way, we are asking if anyone else wants to sign it as an individual or as an org, please do so. Two more signed it just today. Email me if you want your name on it:
ttidmore@pandoranet.info.
On definition and criteria. The researchers do not agree and orgs do not agree on which one should be used. Even those who are well-respected do not all agree. Even Klimas had a few negative comments on the ME-ICC. Jason's name is not on that one and he has a different formula. Nothing has a consensus now, either among researchers or clinicians. It's all just what is best we have at this time. Also, no one from government agency was involved in those, so without their participation, it is very unlikely they will accept any of them.
We don't all agree on the name that should be used. And, as evident here, we don't agree on whether it is one disease with a spectrum (my view) or two diseases (Ember's and ric's view). But that does not stop us from finding areas where we do agree.
We all (researchers and orgs on the letter) do agree that the confusion and the disagreement on this issue needs to be resolved for progress to be made. And, the DHHS is in a position to take the lead in resolving it. They and the agencies they oversee carry some credibility that individual researchers or groups of researchers don't, which is why there are so many criteria in use with no consensus.
Also, I do not agree with Ember's take on the message of the ME-ICC. She and I have discussed this before. And I have not engaged on that issue here as, again, it does not move the cause forward. We have flushed out both viewpoints and discussed evidence, and we still disagree. So, no point in beating a dead horse. But, I am sure I do agree with Ember on many things. And I would like to focus on those areas.
Here is what the letter said in reference to name and criteria and we all, 14 orgs and now 21 individuals agree to it:
Resolve the definition, name and classification confusion. The 1994 Fukuda definition and the 2005 Empirical definition have hopelessly blurred the distinctions between ME/CFS, depression and generalized chronic fatigue. (6,7). They are out of date and do not require the one symptom considered to be a hallmark of the disease: post exertional malaise. Use of this definition has contributed to research results that cannot be effectively compared across studies (6) and has contributed to inappropriate diagnosis and treatment.
In October 2009, the CFS Advisory Committee (CFSAC) recommended that “DHHS recognize a need for and support a national effort to arrive at a consensus definition of CFS that is accurate, standardized and reflective of the true disease.” (7) We support that recommendation. It is long past time to subset Fukuda-defined patients and actively consider the existing 2003 Canadian Consensus Criteria (CCC) or 2011 International Consensus Criteria (ICC) for those patients who suffer from the hallmark post-exertional malaise.
Beyond the definition, the name CFS has been confused with everyday tiredness and “chronic fatigue” ever since the CDC created it in 1988. Yet, many experienced clinicians and researchers recognize the equivalency or close similarity of ME and CFS based on the growth in scientific understanding and have adopted the term ME/CFS. All of DHHS should follow the NIH’s lead and adopt the term ME/CFS as recommended by the CFSAC in October 2010. (8)
As it is now, if you say ME and CFS are different, then NIH is not doing any ME research and CDC is not doing any ME research and all American researchers using Fukuda is not doing any ME research and all their findings of immune abnormalities, brain abnormalities, etc. do not apply to ME patients.
Now, it seems that Ember and Bob can agree that CCC or ICC should be used as the criteria for those with post exertional malaise.
And, to my knowledge, the CFSAC has never recommended that. So, that might be an area where those on Phoenix Rising can agree and also agree with those who signed the letter.
However, I'm sure that is not the only area where there is agreement. I bet we would all agree that the misspent NIH funding should be restored to funding into the disease.
Anyway, again, we are still taking signatures. See a copy of it here:
http://www.coalition4mecfs.org/Joint_Letter.html
If you want your name on it, too, email me at
ttidmore@pandoranet.info.